MEDX ... anybody following? | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
MEDX ... anybody following?

An SI Board Since May 1996

Posts	SubjectMarks	Bans	Symbol
2240	62	0	MEDX

Emcee: Ed Offstein	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1665	Anthrax Monoclonal Antibody Valortim(TM) Demonstrates Therapeutic Effect in New	LJM	-	3/29/2007
1664	Stanford's Wong creates vaccine Brain cancer patients expected to benefit a	Icebrg	-	3/24/2007
1663	Medarex Announces Initiation of Phase I Clinical Trial for the Treatment of Psor	Icebrg	-	3/23/2007
1662	Brain Tumor Vaccine Developed by Stanford Researcher to Be Tested at 20 Sites Na	Icebrg	-	3/23/2007
1661	>>Sweden or Denmark, who really cares?<< Well, now that there's	nigel bates	-	3/18/2007
1660	Clinical importance and therapeutic potential of targeting PD-L/PD-1 pathway in	Icebrg	-	3/17/2007
1659	Medarex initiated with "buy" Friday, March 16, 2007 3:09:35 AM ET A.G	Icebrg	-	3/16/2007
1658	Cancer patient defies the odds By Philip Hennessey A MAN who was told in May th	Icebrg	-	3/16/2007
1657	Targeting T cell negative pathway induces powerful and long-lasting antitumor ef	Icebrg	-	3/16/2007
1656	Genmab A/S Company Announcement New Insights into Novel Mechanisms of Action of	Icebrg	-	3/12/2007
1655	Medx seems to be as Low as is going to get, Great Co. as far as I can tell, eno	TT	-	3/7/2007
1654	TO: All Medarex Employees FROM: Irwin Lerner RE:(1) End of Stock Option Exercise	Icebrg	-	3/7/2007
1653	They have lately been putting all their efforts into the monotherapy - second li	Icebrg	-	3/1/2007
1652	From yesterday's conf. call, I was primarily listening for 010 updates: 1)	software salesperson	-	3/1/2007
1651	IDM Pharma Announces the Completion of Enrollment in Two Phase II Trials of Uvid	Icebrg	-	3/1/2007
1650	>>Medarex Announces 2006 Fourth Quarter and Year End Financial Results Wed	tuck	-	2/28/2007
1649	The combined activation of positive costimulatory signals with modulation of a n	Icebrg	-	2/26/2007
1648	Cool, thanks. Authors.... Maier H, Isogawa M, Freeman GJ, Chisari FV.	scaram(o)uche	-	2/23/2007
1647	PD-1:PD-L1 Interactions Contribute to the Functional Suppression of Virus-Specif	Icebrg	-	2/23/2007
1646	Item 1.01. Entry into a Material Definitive Agreement. The description of the m	Icebrg	-	2/23/2007
1645	Clinical efficacy of zanolimumab (HuMax-CD4): two Phase II studies in refractory	Icebrg	-	2/23/2007
1644	7:04AM Cell Genesys and Medarex announce encouraging follow-up results from a Ph	Doc Bones	-	2/22/2007
1643	IDM Pharma Raises $12.8 Million in Private Placement Wednesday February 21, 8:00	Icebrg	-	2/22/2007
1642	Medarex Announces Sale of Shares in Genmab A/S Tuesday February 20, 7:00 am ET	nigel bates	-	2/20/2007
1641	[Ipilimumab after Cancer Vaccine Failure in Patients with Advanced Malignancy]	tuck	-	2/19/2007

Go to reply# or date (mm/dd/yy):